Zoetis Inc. (ZTS), headquartered in Parsippany, New Jersey, is a global leader in animal health. It specializes in the development, manufacturing, and distribution of medicines, vaccines, and diagnostics for pets and livestock. With a market cap of $87.15 billion, Zoetis serves veterinarians, pet owners, and livestock producers worldwide. The company is set to release its Q3 earnings before the market opens on Monday, Nov. 4. Ahead of the event, analysts expect ZTS to report a profit of $1.46 per share, up 7.4% from $1.36 in the year-ago quarter. The company has missed Wall Street’s earnings e…